ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

October 29, 2004

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988

International Research Data Bank Up And Operating Through NLM Systems

September 20, 1974

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

January 23, 1976